Barchart Analyst Flags Three Dividend Aristocrats Trading Under $100
Screening criteria focused on forward yields, payout ratios between 35% and 65%, and 'Moderate' to 'Strong Buy' ratings from Wall Street.
Barchart analyst Rick Orford has identified three S&P 500 Dividend Aristocrats trading under $100 as suitable long-term investments: McCormick & Company, Medtronic, and Abbott Laboratories. The selection was derived using Barchart’s Stock Screener, applying filters for forward dividend yields, payout ratios between 35% and 65%, and analyst ratings ranging from 'Moderate' to 'Strong Buy'. Orford noted that he did not hold positions in any of the mentioned securities at the time of publication.
McCormick & Company offers a forward annual dividend yield of approximately 4.10%, supported by a 40-year record of consecutive dividend increases. The company recently announced plans to combine with Unilever’s Foods business, a move intended to expand its position in the global flavour market. With a dividend payout ratio of 60%, the company allocates a significant portion of earnings to shareholders while retaining 40% for reinvestment. A consensus among 13 analysts rates the stock a 'Moderate Buy', with target prices suggesting 13% to 36% upside potential.
Medtronic provides a yield of around 3.7% and has increased dividends for 48 consecutive years. The medical technology firm recently saw its Altaviva ankle-implanted treatment for urge urinary incontinence named a 2026 Edison Award winner, recognising breakthrough innovation in the sector. Medtronic maintains a dividend payout ratio of 50%, balancing growth with shareholder value. A consensus of 28 analysts rates the stock a 'Moderate Buy', with upside potential estimated between 17% and 56%.
Abbott Laboratories yields 3% and holds the only 'Strong Buy' consensus on the list, with an average analyst score of 4.43. The healthcare giant’s diabetes care business, specifically the FreeStyle Libre continuous glucose monitoring system, is cited as a key growth driver due to strong global adoption. Abbott maintains a dividend payout ratio of 46% and has the widest upside potential range on the list, with target prices suggesting 8% to 68% growth.
These three stocks were selected from a broader list of 11 results that met the initial screening criteria. Orford emphasised that while dividends add a layer of safety for established businesses, they do not remove market risks. The analysis highlights consistency and stable payouts as key qualities for long-term investors, though target prices are not guaranteed outcomes.
